DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Tartari F, Santoni M, Burattini L, Mazzanti P, Onofri A, Berardi R. et al.
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges.
Cancer Treat Rev 2016;
48: 20-4
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.